China is being viewed by the biotech and life sciences industry as a threat to US innovation. One pharma CEO thinks it may not be the worst thing to happen to the industry.

Treasury Secretary Scott Bessent offered support for Jerome Powell amid regular attacks from Trump administration officials, ...

Astra, led by boss Pascal Soriot (pictured), said it is accelerating its expansion in US with an investment that will create ...

In a vote of confidence for Virginia’s growing life sciences sector, pharmaceutical giant AstraZeneca announced plans to ...

AstraZeneca has announced plans to invest $50 billion in the U.S. by 2030 amid concerns over tariffs. The British pharmaceutical company said its investment would fund a new drug manufacturing ...

A number of other drugmakers have rolled out similar plans to ramp up U.S. manufacturing in recent days, in the face of ...

The announcement by AstroZeneca follows a growing trend of companies pledging to invest in pharmaceutical manufacturing on ...

In a vote of confidence for Virginia’s growing life sciences sector, pharmaceutical giant AstraZeneca announced plans to ...

The U.K.-based drug maker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.

Governor Glenn Youngkin announced Monday that AstraZeneca selected Virginia for a multi-billion-dollar manufacturing center ...

Gov. Glenn Youngkin announced Monday that pharmaceutical giant AstraZeneca will build its largest single manufacturing ...

AstraZeneca plans to construct a multi-billion dollar manufacturing center focused on chronic diseases in Virginia within the next five years.